Marna Taylor
Family · Berkley, MINPI 1861975856
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,654 of the $25,318 with a category attached, or 73.7%. 28 manufacturers reported payments, led by Viiv Healthcare Company at 37.0% of the total. Reporting peaked in 2023 at $9,448 and has fallen 74.0% since, to $2,454 in 2025. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 824 payments — averaging $30.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$9K
- Gilead$9K
- AbbVie$1K
- Merck$871
- Johnson & Johnson$779
- Janssen Products, LP$672
- plus $4K from 22 others
What the payments were for
- Consulting fees$4,14516%
- Travel & lodging$2,3269%
- Food & beverage$18,65474%
- Education$1941%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 286 | $9,376 |
| Gilead | 295 | $8,851 |
| AbbVie | 55 | $1,067 |
| Merck | 33 | $871 |
| Johnson & Johnson(2 entities) | 27 | $779 |
| Janssen Products, LP | 6 | $672 |
| Lilly USA, LLC | 18 | $581 |
| Abbott | 5 | $377 |
| Janssen Scientific Affairs, LLC | 2 | $319 |
| Otsuka America Pharmaceutical, Inc. | 6 | $314 |
| Pfizer | 18 | $273 |
| AstraZeneca | 9 | $269 |
| Napo Pharmaceuticals Inc | 12 | $263 |
| Halozyme Inc | 6 | $212 |
| Antares Pharma, Inc. | 8 | $182 |
| Axsome Therapeutics, Inc. | 7 | $180 |
| Theratechnologies Inc. | 6 | $179 |
| Lundbeck LLC | 8 | $126 |
| Impel Pharmaceuticals Inc. | 1 | $112 |
| Novo Nordisk | 4 | $74 |
| Indivior Inc. | 2 | $47 |
| GSK | 2 | $40 |
| Seqirus USA Inc | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Echosens North America, Inc. | 1 | $30 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Amgen | 1 | $19 |
| Tolmar, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,318 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 40 | $158,097 |
| PrezcobixDarunavir/Cobicistat | 19 | $46,049 |
| TivicayDolutegravir Sodium | 19 | $42,207 |
| DescovyEmtricitabine/Tenofov Alafenam | 16 | $31,462 |
| OzempicSemaglutide | 31 | $29,800 |
| FarxigaDapagliflozin Propanediol | 31 | $21,547 |
| MounjaroTirzepatide | 13 | $15,400 |
| JardianceEmpagliflozin | 19 | $15,369 |
| Lamivudine | 12 | $2,695 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,261 |
| Atorvastatin Calcium | 63 | $351 |
| Fluticasone Propionate | 14 | $157 |
| Levothyroxine Sodium | 15 | $156 |
| Omeprazole | 23 | $155 |
| Lisinopril | 46 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $8,851 | $189,55956 claims |
| Johnson & JohnsonPrezcobix | $779 | $46,04919 claims |
| Viiv Healthcare CompanyTivicay | $9,376 | $42,20719 claims |
| Novo NordiskOzempic | $74 | $29,80031 claims |
| AstraZenecaFarxiga | $269 | $21,54731 claims |
| Lilly USA, LLCMounjaro | $581 | $15,40013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Berkley
- Leon BulloughBerkley$14K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.